Terms: = Pancreatic cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
14 results:
1. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
[TBL] [Abstract] [Full Text] [Related]
2. Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma.
Damanakis A; Plum PS; Gebauer F; Schröder W; Büttner R; Zander T; Bruns CJ; Quaas A
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2287-2293. PubMed ID: 35477823
[TBL] [Abstract] [Full Text] [Related]
3. Outcome of a novel modified endoscopic papillectomy for duodenal major papilla adenoma.
Wang P; Jiang C; Wang Y; Zhou L; Zhang S; Ding X; Lv Y; Wang L; Zou X
Surg Endosc; 2020 Nov; 34(11):5160-5167. PubMed ID: 32666256
[TBL] [Abstract] [Full Text] [Related]
4. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the cyld/RIPK1/FADD/caspase-8-dependent apoptosis.
Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
[TBL] [Abstract] [Full Text] [Related]
5. Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience.
Casadei R; Ricci C; Ingaldi C; Alberici L; Di Marco M; Guido A; Minni F; Serra C
Updates Surg; 2020 Dec; 72(4):1089-1096. PubMed ID: 32399592
[TBL] [Abstract] [Full Text] [Related]
6. Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions.
Saleh A; ElFayoumi HM; Youns M; Barakat W
Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb; 392(2):165-175. PubMed ID: 30465055
[TBL] [Abstract] [Full Text] [Related]
7. cyld deficiency promotes pancreatic cancer development by causing mitotic defects.
Xie S; Wu Y; Hao H; Li J; Guo S; Xie W; Li D; Zhou J; Gao J; Liu M
J Cell Physiol; 2019 Jun; 234(6):9723-9732. PubMed ID: 30362575
[TBL] [Abstract] [Full Text] [Related]
8. 4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation.
Kumar D; Singh G; Sharma P; Qayum A; Mahajan G; Mintoo MJ; Singh SK; Mondhe DM; Bedi PMS; Jain SK; Gupta GK
Anticancer Agents Med Chem; 2018; 18(1):57-73. PubMed ID: 28925877
[TBL] [Abstract] [Full Text] [Related]
9. Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.
Wu GR; Mu TC; Gao ZX; Wang J; Sy MS; Li CY
J Biol Chem; 2017 Nov; 292(46):18747-18759. PubMed ID: 28900035
[TBL] [Abstract] [Full Text] [Related]
10. Anticancer activity of salicin and fenofibrate.
Sabaa M; ELFayoumi HM; Elshazly S; Youns M; Barakat W
Naunyn Schmiedebergs Arch Pharmacol; 2017 Oct; 390(10):1061-1071. PubMed ID: 28733879
[TBL] [Abstract] [Full Text] [Related]
11. Mechanisms of obesity-induced gastrointestinal neoplasia.
Alemán JO; Eusebi LH; Ricciardiello L; Patidar K; Sanyal AJ; Holt PR
Gastroenterology; 2014 Feb; 146(2):357-373. PubMed ID: 24315827
[TBL] [Abstract] [Full Text] [Related]
12. The effect of culture liquid ethyl acetate mycelium extracts of medicinal mushrooms on the viability of human pancreatic cancer cells.
Sharvit LE; Wasser SP; Fares F
Int J Med Mushrooms; 2012; 14(2):169-79. PubMed ID: 22506577
[TBL] [Abstract] [Full Text] [Related]
13. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
Colucci G; Giuliani F; Gebbia V; Biglietto M; Rabitti P; Uomo G; Cigolari S; Testa A; Maiello E; Lopez M
Cancer; 2002 Feb; 94(4):902-10. PubMed ID: 11920457
[TBL] [Abstract] [Full Text] [Related]
14. Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
Wagener DJ; Hoogenraad WJ; Rougier P; Lusinchi A; Taal BG; Veenhof CH; de Graeff A; Conroy T; Curran D; Sahmoud T; Wils J
Eur J Cancer; 1996 Jul; 32A(8):1310-3. PubMed ID: 8869091
[TBL] [Abstract] [Full Text] [Related]
